Table 2.

Concomitant BP-lowering treatment at the end of follow-upa

VariableEnd of Follow-up (n [%])
Perindopril-IndapamidePlacebo
Open-label perindopril2128 (44.5)2591 (54.9)
Other ACEIs232 (4.9)213 (4.5)
ARBs453 (9.5)618 (13.1)
β blockers1492 (31.2)1671 (35.4)
Calcium antagonists1531 (32.0)2040 (43.2)
Thiazide diuretics158 (3.3)217 (4.6)
Other diuretics673 (14.1)749 (15.9)
Other BP-lowering drugs463 (9.7)638 (13.5)
Any BP-lowering drugs3634 (74.0)4024 (82.7)
  • a Reprinted from Patel et al.,18 with permission from Elsevier.